U.S. Global Investors Discloses Material Weakness, Restates Q3 2026 EPS
GROW sits 18% above its 52-week low of $2.2 on elevated volume (2.0× avg).
Summary
U.S. Global Investors will restate its Q3 2026 EPS due to a calculation error and disclosed a material weakness in internal controls, though core financial results remain unchanged.
Key Events · Corporate Governance and Compliance · GROW
-
Non-Reliance on Financial Statements
The Audit Committee concluded that previously issued consolidated financial statements for the three and nine months ended March 31, 2026, should no longer be relied upon.
-
EPS Restatement Due to Calculation Error
Basic and diluted EPS for the three months ended March 31, 2026, were overstated by $0.02, and by $0.01 for the nine-month period, due to an omission in the weighted-average shares calculation.
-
Core Financials Unaffected
The error did not impact the company's revenues, expenses, net income (loss), cash flows, or financial position.
-
Material Weakness in Internal Controls
Management identified a material weakness in internal control over financial reporting as of March 31, 2026, related to a failure in the review control for weighted average shares outstanding.
Analysis · GROW · Finance
The company announced it can no longer rely on its Q3 2026 financial statements due to an error in EPS calculation, leading to a material weakness in internal controls. While the error did not affect core financials like revenue or net income, the disclosure of control deficiencies is a significant governance concern that can impact investor confidence in financial reporting accuracy.
How filings like this one have moved
In the 30 days to Sep 13, 2026, 35.6% of the 1216 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.43%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, GROW was trading at $2.59 on NASDAQ in the Finance sector, with a market capitalization of approximately $26.8M. The 52-week trading range was $2.20 to $3.65. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.